Study shows DNA biomarker can be used to predict outcomes for high risk low grade gliomas
As NCI employees and others at HHS were receiving notices of termination, national cancer organizations called on Congress “to restore stability to NIH.”
Biomarker linked to increased survival rates among certain brain tumor patients
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Chair, radiation oncology, The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Table of Contents
YOU MAY BE INTERESTED IN
An estimated 5,200 of HHS employees have been fired during the course of this week. Since the firings are ongoing, no final tally of their extent exists. At this writing, approximately 1,200 of the fired HHS employees were working at NIH, about 700 at FDA, and 750 at CDC.
Cancer data quoted in President Trump’s executive order last week have raised eyebrows among experts in cancer epidemiology.
Today, our world is small. It feels smaller all the time. In a few hours we can get to any point on the globe.
As cancer clinicians, we spend years learning how to think objectively and rationally when supporting patients who have responded to a cancer diagnosis with anger and fear.
Nearly 30 years ago, while completing an assignment for his master’s degree in public health, Brian Rivers discovered he had a family history of prostate cancer.
